New hope for liver cancer: which combo works best?
NCT ID NCT07340502
First seen Jan 17, 2026 · Last updated May 23, 2026 · Updated 20 times
Summary
This study looks at 364 adults with advanced liver cancer that cannot be removed by surgery. It compares two treatment combinations: one using a standard procedure called TACE plus two drugs, and another using a different procedure called HAIC plus the same two drugs. The goal is to see which approach helps patients live longer without their cancer growing, and which has fewer side effects. Results may help doctors choose the best treatment for each patient.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.